These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 15606031

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence.
    Malaiyandi V, Sellers EM, Tyndale RF.
    Clin Pharmacol Ther; 2005 Mar; 77(3):145-58. PubMed ID: 15735609
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Modified nicotine metabolism in transgenic tobacco plants expressing the human cytochrome P450 2A6 cDNA.
    Dueckershoff K, Unger M, Frank A, Gillam EM, Guengerich FP, Warzecha H.
    FEBS Lett; 2005 Apr 25; 579(11):2480-4. PubMed ID: 15848192
    [Abstract] [Full Text] [Related]

  • 5. Smoking behavior and related cancers: the role of CYP2A6 polymorphisms.
    Nakajima M.
    Curr Opin Mol Ther; 2007 Dec 25; 9(6):538-44. PubMed ID: 18041664
    [Abstract] [Full Text] [Related]

  • 6. [Researches on the polymorphism of cytochrome P450 2A6].
    Tong Z, ZhuGe J, Yu Y.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Oct 25; 19(5):424-7. PubMed ID: 12362322
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Decreasing smoking behaviour and risk through CYP2A6 inhibition.
    Sellers EM, Tyndale RF, Fernandes LC.
    Drug Discov Today; 2003 Jun 01; 8(11):487-93. PubMed ID: 12818518
    [Abstract] [Full Text] [Related]

  • 9. Genetic polymorphisms in the cytochrome P450 2A6 (CYP2A6) gene: implications for interindividual differences in nicotine metabolism.
    Oscarson M.
    Drug Metab Dispos; 2001 Feb 01; 29(2):91-5. PubMed ID: 11159795
    [Abstract] [Full Text] [Related]

  • 10. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans.
    Nakajima M, Kwon JT, Tanaka N, Zenta T, Yamamoto Y, Yamamoto H, Yamazaki H, Yamamoto T, Kuroiwa Y, Yokoi T.
    Clin Pharmacol Ther; 2001 Jan 01; 69(1):72-8. PubMed ID: 11180041
    [Abstract] [Full Text] [Related]

  • 11. Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity.
    Dempsey D, Tutka P, Jacob P, Allen F, Schoedel K, Tyndale RF, Benowitz NL.
    Clin Pharmacol Ther; 2004 Jul 01; 76(1):64-72. PubMed ID: 15229465
    [Abstract] [Full Text] [Related]

  • 12. Effects of polymorphism in promoter region of human CYP2A6 gene (CYP2A6*9) on expression level of messenger ribonucleic acid and enzymatic activity in vivo and in vitro.
    Yoshida R, Nakajima M, Nishimura K, Tokudome S, Kwon JT, Yokoi T.
    Clin Pharmacol Ther; 2003 Jul 01; 74(1):69-76. PubMed ID: 12844137
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A novel polymorphism of human CYP2A6 gene CYP2A6*17 has an amino acid substitution (V365M) that decreases enzymatic activity in vitro and in vivo.
    Fukami T, Nakajima M, Yoshida R, Tsuchiya Y, Fujiki Y, Katoh M, McLeod HL, Yokoi T.
    Clin Pharmacol Ther; 2004 Dec 01; 76(6):519-27. PubMed ID: 15592323
    [Abstract] [Full Text] [Related]

  • 15. Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour.
    Tricker AR.
    Toxicology; 2003 Feb 01; 183(1-3):151-73. PubMed ID: 12504349
    [Abstract] [Full Text] [Related]

  • 16. CYP2A6 polymorphism, nicotine, and environmental nitrosamines.
    Idle JR.
    Lancet; 1999 Jun 12; 353(9169):2073. PubMed ID: 10376647
    [No Abstract] [Full Text] [Related]

  • 17. Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations.
    Nakajima M, Fukami T, Yamanaka H, Higashi E, Sakai H, Yoshida R, Kwon JT, McLeod HL, Yokoi T.
    Clin Pharmacol Ther; 2006 Sep 12; 80(3):282-97. PubMed ID: 16952495
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. CYP2A6 genotype and the metabolism and disposition kinetics of nicotine.
    Benowitz NL, Swan GE, Jacob P, Lessov-Schlaggar CN, Tyndale RF.
    Clin Pharmacol Ther; 2006 Nov 12; 80(5):457-67. PubMed ID: 17112802
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.